Advanced Or Metastatic Solid Tumor clinical trials

Explore recruiting advanced or metastatic solid tumor clinical trials.

Recruiting advanced or metastatic solid tumor studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Or Metastatic Solid Tumor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1/2 Dose Escalation/Expansion Study of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

France, Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

TIRACAN; Open label phase 2 basket trial with Atezolizumab and Tiragolumab in solid tumors

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1/2, Open-label, Dose Escalation and Dose Expansion Study of TransCon TLR7/8 Agonist Alone or in Combination with Pembrolizumab in Participants with Locally Advanced or Metastatic Solid Tumor Malignancies

Spain, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A study evaluating the safety, tolerability, pharmacokinetics, and activity of RO7566802 given alone and in combination with atezolizumab in patients with locally advanced or metastatic solid tumor malignancies

Spain, Czechia

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1, Open-Label, Dose-Escalation Study to Determine an Appropriate Starting Dose of Sacituzumab Govitecan in Subjects With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

France, Spain, Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

Advanced Or Metastatic Solid Tumor trials by city

Advanced Or Metastatic Solid Tumor in Toronto Advanced Or Metastatic Solid Tumor in Vancouver Advanced Or Metastatic Solid Tumor in Montreal Advanced Or Metastatic Solid Tumor in Calgary Advanced Or Metastatic Solid Tumor in Edmonton Advanced Or Metastatic Solid Tumor in Ottawa Advanced Or Metastatic Solid Tumor in Winnipeg Advanced Or Metastatic Solid Tumor in Quebec City Advanced Or Metastatic Solid Tumor in Hamilton Advanced Or Metastatic Solid Tumor in Kitchener Advanced Or Metastatic Solid Tumor in London Advanced Or Metastatic Solid Tumor in Halifax Advanced Or Metastatic Solid Tumor in New York Advanced Or Metastatic Solid Tumor in Los Angeles Advanced Or Metastatic Solid Tumor in Chicago Advanced Or Metastatic Solid Tumor in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease